EP Vantage is a forward-looking comment and analysis service tailored to the needs of pharma and finance professionals, focusing on the events that will define the future of companies, products and therapy areas. Written by experienced journalists, EP Vantage provides timely financial analysis of regulatory and patent decisions, marketing approvals, licensing deals, and M&A, giving fresh angles and insight to both current and future industry triggers. EP Vantage is powered by EvaluatePharma, the industry leader in consensus forecasts.
Senior Economics Major at Texas A&M University, Class of 2018. Member of Aggie Investment Club. Participant in the 2017 Seeking Alpha Stock Pitch Competition. My intended writing focus is geared towards a combination of both Technical and Fundamental Analysis of stocks with a possibility of outperforming indexes.